Philadelphia Business JournalMontco biopharm to collaborate with the Parker Institute for Cancer ImmunotherapyPhiladelphia Business JournalThe initial trial under consideration between Inovio (NASDAQ: INO) of Plymouth Meeting and the Parker Institute w… Continue reading
Pain News NetworkNew stem cell method sheds light on a tell-tale sign of heart diseaseScience DailyThe team, led by Morgridge Institute Fellow Dave Vereide, describes in the Jan. 9, 2018 issue of Stem Cell Research a new method of creating human arteri… Continue reading
Deep sea creatures provide a guiding light in the quest to develop cancer therapiesScience Daily"One of the most promising areas in cancer research is immunotherapy, including chimeric antigen receptor-T (CAR-T) cells. It is also one of the most d… Continue reading
Synthetic Biology Workstation Market 2018 Trends and 2022 …Digital JournalMarket Opportunity by ApplicationPART 8: Customer LandscapePART 9: Regional Landscape.Systems Biology and Synthetic BiologyMilTechall 3 news articles »… Continue reading
Newsmax |
Gene Therapy, ‘Medical Chips’ Top Advances Predicted for 2018
Newsmax The advance marks the latest in a series of breakthoughs in gene therapy that have emerged in recent years, from new medications that target gene defects to diagnostic tests for heart disease, cancer, and Alzheimer’s disease. Genetics are expected to … |
Rare Disease Report |
BioMarin CEO Speaks on Gene Therapy for Hemophilia at JP Morgan
Rare Disease Report At the annual J.P. Morgan Healthcare Conference in San Francisco, BioMarin Chief Executive Officer Jean-Jacques Bienaime spoke about the company’s development of valoctocogene roxaparvovec, a gene therapy in development for the treatment of Hemophilia … |